Gainers
- YS Biopharma Co (NASDAQ:YS) stock rose 43.0% to $1.08 during Thursday's after-market session. Today's trading volume for this security ended up closing at 1.6 million shares, which is 267.1 percent of its average volume over the last 100 days. The company's market cap stands at $100.5 million.
- Lucy Scientific Discovery (NASDAQ:LSDI) shares rose 10.3% to $0.64. The market value of their outstanding shares is at $11.0 million.
- Modular Medical (NASDAQ:MODD) shares moved upwards by 6.25% to $1.36. The company's market cap stands at $28.6 million.
- Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 6.24% to $0.85. The market value of their outstanding shares is at $192.2 million.
- Omega Therapeutics (NASDAQ:OMGA) shares rose 4.99% to $3.78. The company's market cap stands at $208.4 million.
- Singular Genomics Sys (NASDAQ:OMIC) stock rose 4.99% to $0.49. The market value of their outstanding shares is at $36.1 million.
Losers
- Myomo (AMEX:MYO) stock fell 18.7% to $0.61 during Thursday's after-market session. At the close, Myomo's trading volume reached 151.2K shares. This is 39.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $12.8 million.
- Aeglea BioTherapeutics (NASDAQ:AGLE) stock decreased by 10.26% to $0.49. The market value of their outstanding shares is at $49.5 million.
- Minerva Surgical (NASDAQ:UTRS) shares decreased by 8.0% to $0.23. Today's trading volume for this security ended up closing at 1.1 million shares, which is 27.2 percent of its average volume over the last 100 days. The company's market cap stands at $40.8 million.
- SeqLL (NASDAQ:SQL) stock fell 7.92% to $0.3. The company's market cap stands at $4.1 million.
- Nemaura Medical (NASDAQ:NMRD) shares fell 7.6% to $0.55. The company's market cap stands at $15.7 million.
- Cue Health (NASDAQ:HLTH) shares decreased by 7.01% to $0.5. Trading volume for this security closed at 52.2K, accounting for 5.8% of its average full-day volume over the last 100 days. The company's market cap stands at $77.2 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.